Psychotherapy Provides Long-Term IBS Benefits
Psychological therapies are known to provide short-term symptom relief to patients with irritable bowel syndrome, but the results of a recent study indicate that these benefits may extend even longer than previously thought.
Psychological therapies are known to provide short-term symptom relief to patients with irritable bowel syndrome (IBS), but the results of a recent study indicate that these benefits may extend even longer than previously thought. The study, published in Clinical Gastroenterology and Hepatology, examined data on more than 2200 patients with IBS across 41 clinical trials. Based on this meta-analysis, the research team determined that the IBS benefits afforded by psychotherapy lasted at least 6 to 12 months after the conclusion of therapy.
The researchers found no significant difference in efficiency between different types of psychotherapy, such as cognitive therapies, relaxation, and hypnosis. The length of the treatment or number of sessions were also found to have little effect on potential benefits. In addition, online therapy was discovered to be comparable to in-person treatments in effectiveness.
“Western medicine often conceptualizes the mind as separate from the body, but IBS is a perfect example of how the two are connected,” said study author and doctoral student Kelsey Laird in a press release. “Gastrointestinal symptoms can increase stress and anxiety, which can increase the severity of the symptoms. This is a vicious cycle that psychological treatment can help break.”
Laird and her colleagues plan to follow up on their findings by investigating how psychological therapy influences patients’ ability to perform daily functions, such as working, going to school, or participating in social activities.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025